Currently submitted to: JMIR Research Protocols
Date Submitted: Feb 8, 2025
Open Peer Review Period: Feb 10, 2025 - Apr 7, 2025
(currently open for review)
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Sitting Baduanjin Combined with Acupoint Massage on Frailty in Maintenance Hemodialysis Patients: Study protocol of a randomized controlled trial
ABSTRACT
Background:
Patients with maintenance hemodialysis suffer from weakness due to prolonged dialysis treatment, such as the continuous decline of muscle strength in patients, which will have varying degrees of impact on human physiological, psychological and social functions. Effective non-pharmacological interventions can improve their mental health and quality of life.
Objective:
This study aimed to investigate the effects of sitting Baduanjin combined with acupoint massage on improving the frailty status of patients undergoing maintenance hemodialysis (MHD) and evaluate whether it can significantly improve their physical activity, alleviate depressive emotions, and comprehensively improve their quality of life.
Methods:
This study included 114 patients treated using MHD at the Affiliated Hospital of Chengdu University of Traditional Chinese Medicine between March 2024 and October 2024. A randomized controlled study design was used. Patients who met the inclusion and exclusion criteria were randomly divided into three groups: the control group received only conventional hemodialysis and care, the acupoint massage group received acupoint massage treatment in addition to the control group treatment, and the sitting Baduanjin combined with acupoint massage group that received sitting Baduanjin combined with acupoint massage and the control group treatment. The clinical efficacy was comprehensively evaluated by comparing the FRAIL scale scores, grip strength, 10 times sit-to-stand test, Self-Rating Depression Scale scores, and quality of life (SF-36) scores before and after eight weeks of treatment among the three groups. Statistical analysis was conducted using the Statistical Package for the Social Sciences software (version 25.0).
Results:
The study began enrollment in September 2024. To date, 114 participants have finished the baseline questionnaires.
Conclusions:
The results of this study can provide scientific basis for the future treatment of patients with asthenia in hemodialysis. Clinical Trial: This study was registered under the registration number ITMCTR2024000798 on November 12, 2024,
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.